1 Min Read
April 4 (Reuters) - Prescient Therapeutics Ltd:
* Requests trading halt pending an announcement to market in relation to results from company’s phase 1b breast cancer trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.